Search for: "Anda Inc." Results 81 - 100 of 960
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Salix Pharmaceuticals, Ltd. v. Norwich Pharmaceuticals Inc. (Fed. Cir. 2024)
24 Apr 2024, 9:27 pm by Patent Docs
Vivitro Labs, Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Hatch-Waxman Liability May Apply to Entities Involved in ANDA Preparation
23 Oct 2012, 7:08 am by Docket Navigator
Varam, Inc., et. al., 1-10-cv-06038 (NYSD October 19, 2012, Order) (Stein, J.). [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Sanofi-Synthelabo v. Apotex, Inc. (Fed. Cir. 2008)
16 Dec 2008, 5:16 am
Sanofi-Synthelabo, Sanofi-Synthelabo, Inc., and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively, Sanofi) brought suit under 35 U.S.C. [read post]
Patent Docs - http://www.patentdocs.org/
Sanofi-Aventis U.S. LLC v. Sandoz, Inc. (Fed. Cir. 2009)
10 Sep 2009, 9:59 pm
Sandoz, Inc.(1), arose as the result of ANDA filings by several Defendants for oxaliplatin, the active ingredient in Sanofi's Eloxatin ® colorectal cancer drug. [read post]
Patent Docs - http://www.patentdocs.org/
Ortho-McNeil Pharmaceutical, Inc. v. Mylan Laboratories Inc. (Fed. Cir. 2009)
10 Jun 2009, 9:02 pm
Seeking approval to market a generic version of levofloxacin, Defendants-Appellants Mylan Laboratories Inc. and Mylan Pharmaceuticals Inc. filed an Abbreviated New Drug Application (ANDA) with the FDA. [read post]
Patent Docs - http://www.patentdocs.org/
Hatch-Waxman Bars Declaratory Relief Claim Against ANDA Applicant's Prospective Supplier
9 Apr 2014, 7:03 am by Docket Navigator
Sandoz, Inc., 3-12-cv-01617 (NJD March 31, 2014, Order) (Sheridan, J.) [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Judge Sleet Finds that Actavis’ Proposed ANDA Products Infringe Recro’s Asserted Patents
27 Feb 2017, 11:16 am by Gregory B. Williams
Actavis Laboratories FL, Inc., Civil Action No. 14-1118-GMS (D.Del. [read post]
Delaware Intellectual Property Litigation - http://delawareintellectualproperty.foxrothschild.com/
FTC’s Campaign Against Improper Orange Book Listings Continues with Amicus Brief in Teva’s Challenge of Amneal Asthma Inhaler ANDA
3 Apr 2024, 1:07 pm by Bevin Newman
The Federal Trade Commission (“FTC”) has filed an amicus brief in Teva Branded Pharmaceuticals Products R&D, Inc. v. [read post]
Antitrust Law Blog - http://www.antitrustlawblog.com/
ANDA Automatic Stay of FDA Approval Does Not Defeat Standing in Sham Litigation Antitrust Counterclaim
20 Sep 2011, 2:26 pm by Don T. Hibner, Jr.
Shionogi Pharma, Inc. v. [read post]
Antitrust Law Blog - http://www.antitrustlawblog.com/
More Venue and Corporate Games: This time with ANDA filing
8 Nov 2021, 4:39 am by Dennis Crouch
(MPI), Mylan Inc., and Mylan N.V. [read post]
Patently-O - http://patentlyo.com/patent
Valeant Pharmaceuticals Int'l v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2020)
8 Apr 2020, 9:59 pm by Patent Docs
Mylan Pharmaceuticals Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Indivior Inc. v. Dr. Reddy's Laboratories, S.A. (Fed. Cir. 2019)
24 Jul 2019, 9:46 pm by Patent Docs
Noonan -- Last month, the Federal Circuit affirmed decisions from four separate trials in the District of Delaware involving seven different defendants regarding validity and infringement of patents directed to an opioid addiction treatment in Indivior Inc. v. [read post]
Patent Docs - http://www.patentdocs.org/
Court rejects argument that, under the circumstances, lack of Paragraph IV certification means no act of infringement and no jurisdiction.
5 Mar 2012, 10:30 am by James L. Higgins
Cephalon, Inc. v. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/
Court Report
12 Apr 2015, 7:45 pm by Patent Docs
• Defendants: Actavis Inc.; Actavis Laboratories FL, Inc.; Activis Pharma, Inc.; Watson Laboratories, Inc.; Anda, Inc. [read post]
Patent Docs - http://www.patentdocs.org/
Generic's Bioequivalence With Brand Name Drug Does Not Establish Infringement of Patent Protecting Brand Name Drug
17 Mar 2011, 7:47 am by The Docket Navigator
" Cephalon Inc., et. al. v. [read post]
Docket Report Patent Infringement Blog - http://docketreport.blogspot.com/
Momenta Pharmaceuticals, Inc. v. Amphastar Pharmaceuticals, Inc. (Fed. Cir. 2012)
9 Aug 2012, 9:59 pm by Patent Docs
The case involved a District Court grant of a preliminary injunction to Momenta in litigation between two ANDA filers. [read post]
Patent Docs - http://www.patentdocs.org/
Bristol-Myers Squibb, Pfizer file ANDA lawsuits against makers of generic Eliquis
12 Apr 2017, 10:15 am by Steve Brachmann
(NYSE:BMY) and Pfizer, Inc. [read post]
IPWatchdog - http://www.ipwatchdog.com/
Acorda Therapeutics v. Mylan Pharmaceuticals May Not be the Last Word on Personal Jurisdiction in ANDA Cases
2 May 2016, 6:17 am by Paul Dietze Ph.D.
The Federal Circuit held that Mylan Pharmaceuticals, Inc. [read post]
IPWatchdog - http://www.ipwatchdog.com/
The Recent Federal Circuit Decision in Acorda Therapeutics v. Mylan Pharmaceuticals May Not be the Last Word on Personal Jurisdiction in ANDA Cases
3 May 2016, 9:00 pm by Dennis Crouch
Inc. [read post]
Patently-O - http://patentlyo.com/patent
Judge Stark Explains Remedies for an Infringing ANDA
25 May 2012, 11:32 am by Robert Vrana
Mylan Pharmaceuticals Inc., C.A. [read post]
Delaware IP Law Blog - http://www.delawareiplaw.com/